Abstract
During the COVID-19 pandemic, predicting case spikes at the local level is important for a precise, targeted public health response and is generally done with compartmental models. The performance of compartmental models is highly dependent on the accuracy of their assumptions about disease dynamics within a population; thus, such models are susceptible to human error, unexpected events, or unknown characteristics of a novel infectious agent like COVID-19. We present a relatively non-parametric random forest model that forecasts the number of COVID-19 cases at the U.S. county level. Its most prioritized training features are derived from easily accessible, standard epidemiological data (i.e., regional test positivity rate) and the effective reproduction number (Rt) from compartmental models. A novel input training feature is case projections generated by aligning estimated effective reproduction number (pre-computed by COVIDActNow.org) with real time testing data until maximally correlated, helping our model fit better to the epidemic’s trajectory as ascertained by traditional models. Poor reliability of Rt is partially mitigated with dynamic population mobility and prevalence and mortality of non-COVID-19 diseases to gauge population disease susceptibility. The model was used to generate forecasts for 1, 2, 3, and 4 weeks into the future for each reference week within 11/01/2020 - 01/10/2021 for 3068 counties. Over this time period, it maintained a mean absolute error (MAE) of less than 300 weekly cases/100,000 and consistently outperformed or performed comparably with gold-standard compartmental models. Furthermore, it holds great potential in ensemble modeling due to its potential for a more expansive training feature set while maintaining good performance and limited resource utilization.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received to support this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
jgalasso{at}udallas.edu
dcao{at}udallas.edu
hochberg{at}udallas.edu
Data Availability
All code and program supporting the conclusions made in this article is publicly available on GitHub. Our repository can be found at https://github.com/solveforj/pandemic-central. Our weekly forecasts are updated and visualized at https://itsonit.com.
